Truist Securities Reiterates CorMedix (CRMD) at Buy, Calls DefenCath NDA Resubmission a "Huge Relief"

Go back to Truist Securities Reiterates CorMedix (CRMD) at Buy, Calls DefenCath NDA Resubmission a "Huge Relief"
CORMEDIX, Inc. (NASDAQ: CRMD) Delayed: 7.95 +0.85 (11.97%)
Previous Close $7.10    52 Week High $4.54 
Open $8.39    52 Week Low $1.15 
Day High $8.98    P/E N/A 
Day Low $7.76    EPS $-0.55 
Volume 4,237,481